The New England Compounding Center (NECC) has established a Recall Operations Center in order to properly remove its products from circulation, according to a press release from the company.
The compounding pharmacy issued a recall of all its products on October 6 as a precautionary measure - though it maintains there is no cause for concern regarding other products. The U.S. Food and Drug Administration and Centers for Disease Control and Prevention, along with the Massachusetts Board of Registration in Pharmacy, are investigating NECC.
The company said in its press release it is working closely with these agencies to determine the source of infection in the steroid injections.
For more information and a list of states and facilities affected by this recall, visit http://www.cdc.gov/HAI/outbreaks/meningitis.html.
You can also visit the pharmacy's website at http://www.neccrx.com, where you can find a full list of recalled products.
Any adverse reactions or quality problems associated with the company's products should be reported to the FDA's MedWatch Adverse Event Reporting program.
Brad Puffer, director of communications for the office of Massachusetts Attorney General Martha Coakley, said he could not "confirm or deny" a criminal investigation into the company.
0 comments:
Post a Comment